MU Medical Researchers Advance In Metabolic Syndrome Research
Researchers at Marshall University's Joan C. Edwards School of Medicine say they have successfully demonstrated that a particular peptide, or compound consisting of two or more amino acids linked in a chain, may be useful in combating nonalcoholic fatty liver disease and atherosclerosis. The peptide, known as pNaKtide, is designed to block the oxidant-amplifying function of the body's cellular sodium-potassium pump. The peptide's potential effects on experimental nonalcoholic fatty liver disease and atherosclerosis were published in the March 15 edition of "Scientific Reports," an online journal from the publishers of Nature.
NYMC Mention: Nader G. Abraham, Ph.D., professor of medicine and pharmacology